v3.26.3
Consolidated Balance Sheets
$ in Thousands
Sep. 30, 2026
USD ($)
shares
Jun. 30, 2026
USD ($)
shares
Current assets:    
Cash and Cash Equivalent $ 120,127 $ 248,851
Accounts Receivable, after Allowance for Credit Loss, Current 87,381 73,621
Inventory 153,741 136,982
Prepaid expenses and other current assets 110,978 104,998
Asset, Held-for-Sale, Not Part of Disposal Group, Current 46,303 0
Total current assets 518,530 564,452
Property, plant and equipment, net 404,744 367,160
Operating lease assets, net 118,166 121,022
Software and website development costs, net 104,735 106,788
Deferred tax assets 52,356 50,930
Goodwill 882,633 850,778
Intangible assets, net 87,944 70,580
Other assets 75,774 70,801
Total assets 2,244,882 2,202,511
Current liabilities:    
Accounts payable 304,814 333,252
Accrued expenses 351,028 324,744
Deferred revenue 56,991 48,534
Short-term debt [1],[2] 49,487 14,620
Operating lease liabilities, current 25,238 24,753
Other current liabilities 29,331 29,687
Total current liabilities 816,889 775,590
Deferred tax liabilities 31,471 24,487
Long-term debt 1,594,683 1,597,361
Operating lease liabilities, non-current 101,234 102,549
Other liabilities 101,653 100,801
Total liabilities 2,645,930 2,600,788
Temporary equity    
Redeemable noncontrolling interests (Note 11) $ 78,361 $ 75,567
Preferred shares, shares authorized | shares 100,000,000 100,000,000
Ordinary shares, shares authorized | shares 100,000,000 100,000,000
Shareholders’ deficit:    
Preferred shares, nominal value €0.01 per share, 100,000,000 shares authorized; none issued and outstanding $ 0 $ 0
Ordinary shares, shares issued | shares 42,590,059 42,318,634
Common Stock, Shares, Outstanding | shares 24,618,812 24,347,387
Ordinary shares, nominal value €0.01 per share, 100,000,000 shares authorized; 42,590,059 and 42,318,634 shares issued, respectively; 24,618,812 and 24,347,387 shares outstanding, respectively $ 599 $ 596
Treasury Stock, Shares | shares 17,971,247 17,971,247
Treasury shares, at cost, 17,971,247 shares for both periods presented $ (1,363,550) $ (1,363,550)
Additional paid-in capital 624,893 623,454
Retained earnings 275,690 279,418
Accumulated other comprehensive loss (36,883) (33,903)
Total shareholders’ deficit attributable to Cimpress plc (499,251) (493,985)
Noncontrolling Interest 19,842 20,141
Total shareholders' deficit (479,409) (473,844)
Total liabilities, noncontrolling interests and shareholders’ deficit $ 2,244,882 $ 2,202,511
[1] Balances as of September 30, 2026 and June 30, 2026 are inclusive of short-term debt issuance costs, debt premiums and discounts of $3,852 in both periods presented.
[2] The increase in short-term debt is due to $35,000 of borrowings on our senior secured revolving credit facility during the current quarter. The borrowings were used to fund the acquisition of our Saxoprint business. Refer to Note 6 for additional details.